IBX 0.00% 7.4¢ imagion biosystems limited

JOURNEY to 50c plus, page-587

  1. 198 Posts.
    lightbulb Created with Sketch. 164
    Check out slide 24 of Patry's recent Corporate Presentation, to get a sampling of what some Licensing, Alliance, Co-Developement, and or Strategic Collaboration Deals were worth over the past few years. Both total worth and upfront payments.
    https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02562739-3A601248?access_token=83ff96335c2d45a094df02a206a39ff4

    Imagion has stated several times the current trial is not only about safety, but also to prove out efficacy, and derisk the technology. Once derisked, they would shop for such deals similar to those shown above. They also stated several times they've been contacted by such Companies inquiring as far back as several years ago. While the deal sought would be slightly different in nature than those displayed in slide 24 of Patry's Presentation, it would include medical device manufacturing and a % cut of NP's revenue.

    If this deal is inked in time, the likelihood of a cash raise anytime soon would be null and void.

 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.